FDA-Approved Intranasal Esketamine (SPRAVATO™) for Depression in Bethesda, Maryland, Columbia, Maryland, Laurel, Maryland, Washington, D.C., McLean, Virginia, Arlington, Virginia, and other areas in the DMV
Avesta Ketamine and Wellness is now an eligible provider of SPRAVATO™, serving residents across all of Washington DC, Northern Virginia including McLean, Arlington, Fairfax, Falls Church, and Maryland including Bethesda, Columbia, Laurel and other areas in the DMV. SPRAVATO™ (esketamine) CIII is a nasal spray that is best used in conjunction with an oral antidepressant, for the treatment of treatment-resistant depression (TRD) in adults and depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior. Spravato is similar to IV ketamine, however, Spravato and IV ketamine are not the same drug. Spravato is esketamine – a compound derived from the ketamine compound.
Spravato Treatment Considerations
If your insurance covers the cost of the drug and reimburses you for the clinic monitoring time, then Spravato may be right for you. However, if your insurance only covers a part of the above, it is advised that you weigh that against
- The cost of the IV treatments,
- The time it takes to do IV (60 min infusion) versus Spravato (150 minutes in the clinic)
What to Expect From Treatments
Timeline
Treatment induction entails a twice weekly dosage for 4 weeks, then a 1 time per week dosage for another 4 weeks. After 8 weeks patients begin tapering down to every other week, or weekly depending on individual response.
Effectiveness
In general, patients feel effects within the first 24 hours, and are recommended to continue their regular care with a mental health practitioner, as well as their current drug regimen.
Response
The response to Spravato can vary but most patients feeling the effects within 24 hours.
Spravato Treatment in Maryland, Virginia and D.C.
Please contact us so that we can understand your insurance benefits and the easiest way of getting you started on your Spravato treatments in Maryland, Virginia or Washington, D.C.
